Kyowa Kirin funds independent research and education to advance patient outcomes in rare blood cancers and bone/mineral diseases, focusing on innovative therapies and health equity.
Funder: Kyowa Kirin
Due Dates: June 15, 2026: Full application deadline — Applications due (CME RFP / grant)
Funding Amounts: Typical awards range from $5,000 to $100,000 per project; amount depends on project scope and budget.
Summary: Supports independent research, educational, and community initiatives advancing patient outcomes in rare hematologic cancers and bone/mineral diseases.
Key Information: Proposals must focus on rare hematologic or bone diseases and be submitted by eligible organizations, not individuals or physician practices.
Kyowa Kirin provides grants to support independent research, educational programs, and community initiatives that align with their mission to improve outcomes for patients, families, and healthcare professionals. The focus is on rare conditions in hematologic cancers and bone/mineral diseases, with an emphasis on advanced therapeutic antibodies and hematopoietic stem cell gene therapies. Grants may fund medical education, fellowships, data collection, patient registries, investigator-sponsored research, publication of new research, patient education resources, outreach, and efforts to address healthcare disparities and social determinants of health. Kyowa Kirin operates through an arms-length agreement, providing funding but not participating in project management.